Annual Cash & Cash Equivalents
$2.33 M
-$10.38 M-81.68%
December 31, 2022
Summary
- As of February 10, 2025, ACER annual cash & cash equivalents is $2.33 million, with the most recent change of -$10.38 million (-81.68%) on December 31, 2022.
- During the last 3 years, ACER annual cash & cash equivalents has fallen by -$9.75 million (-80.71%).
Performance
ACER Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$1.55 M
-$4.83 M-75.65%
June 30, 2023
Summary
- As of February 10, 2025, ACER quarterly cash and cash equivalents is $1.55 million, with the most recent change of -$4.83 million (-75.65%) on June 30, 2023.
- Over the past year, ACER quarterly cash and cash equivalents has dropped by -$12.92 million (-89.26%).
Performance
ACER Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
ACER Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -81.7% | -89.3% |
| 3 y3 years | -80.7% | -73.6% |
| 5 y5 years | -85.1% | -81.4% |
ACER Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -81.7% | at low | -92.5% | at low |
| 5 y | 5-year | -81.7% | at low | -93.0% | at low |
| alltime | all time | -94.4% | -100.0% | -96.6% | -100.0% |
Acer Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $1.55 M(-75.7%) |
| Mar 2023 | - | $6.38 M(+173.9%) |
| Dec 2022 | $2.33 M(-81.7%) | $2.33 M(-63.5%) |
| Sep 2022 | - | $6.38 M(-55.9%) |
| Jun 2022 | - | $14.47 M(-30.4%) |
| Mar 2022 | - | $20.80 M(+63.6%) |
| Dec 2021 | $12.71 M(+120.6%) | $12.71 M(-10.2%) |
| Sep 2021 | - | $14.15 M(-36.0%) |
| Jun 2021 | - | $22.13 M(+39.2%) |
| Mar 2021 | - | $15.90 M(+176.0%) |
| Dec 2020 | $5.76 M(-52.3%) | $5.76 M(-6.4%) |
| Sep 2020 | - | $6.16 M(+4.7%) |
| Jun 2020 | - | $5.88 M(-16.1%) |
| Mar 2020 | - | $7.01 M(-42.0%) |
| Dec 2019 | $12.08 M(-71.0%) | $12.08 M(-25.1%) |
| Sep 2019 | - | $16.12 M(-31.4%) |
| Jun 2019 | - | $23.49 M(-26.2%) |
| Mar 2019 | - | $31.83 M(-23.6%) |
| Dec 2018 | $41.67 M(+166.4%) | $41.67 M(-9.8%) |
| Sep 2018 | - | $46.19 M(+453.5%) |
| Jun 2018 | - | $8.34 M(-32.5%) |
| Mar 2018 | - | $12.37 M(-20.9%) |
| Dec 2017 | $15.64 M(+354.1%) | $15.64 M(+86.1%) |
| Sep 2017 | - | $8.40 M(+360.7%) |
| Jun 2017 | - | $1.82 M(-35.4%) |
| Mar 2017 | - | $2.82 M(-18.1%) |
| Dec 2016 | $3.44 M(-72.6%) | $3.44 M(-40.7%) |
| Sep 2016 | - | $5.81 M(-25.9%) |
| Jun 2016 | - | $7.85 M(-21.2%) |
| Mar 2016 | - | $9.96 M(-20.9%) |
| Dec 2015 | $12.58 M(+27.0%) | $12.58 M(-19.3%) |
| Sep 2015 | - | $15.59 M(-14.7%) |
| Jun 2015 | - | $18.28 M(+91.0%) |
| Mar 2015 | - | $9.57 M(-3.4%) |
| Dec 2014 | $9.91 M(-58.1%) | $9.91 M(-27.4%) |
| Sep 2014 | - | $13.64 M(-15.9%) |
| Jun 2014 | - | $16.21 M(-17.5%) |
| Mar 2014 | - | $19.66 M(-16.9%) |
| Dec 2013 | $23.64 M(+3894.0%) | $23.64 M(+17.2%) |
| Sep 2013 | - | $20.17 M(+301.2%) |
| Jun 2013 | - | $5.03 M(-35.8%) |
| Mar 2013 | - | $7.83 M(+1223.4%) |
| Dec 2012 | $592.00 K(-91.7%) | $592.00 K(-73.5%) |
| Sep 2012 | - | $2.24 M(+42.5%) |
| Jun 2012 | - | $1.57 M(-66.4%) |
| Mar 2012 | - | $4.68 M(-34.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $7.11 M(+86.5%) | $7.11 M(-17.7%) |
| Sep 2011 | - | $8.64 M(-12.5%) |
| Jun 2011 | - | $9.88 M(-13.6%) |
| Mar 2011 | - | $11.43 M(+199.8%) |
| Dec 2010 | $3.81 M(-53.4%) | $3.81 M(-19.5%) |
| Sep 2010 | - | $4.73 M(-19.4%) |
| Jun 2010 | - | $5.87 M(-17.2%) |
| Mar 2010 | - | $7.09 M(-13.3%) |
| Dec 2009 | $8.18 M(+558.1%) | $8.18 M(+107.0%) |
| Sep 2009 | - | $3.95 M(+377.9%) |
| Jun 2009 | - | $827.00 K(+104.8%) |
| Mar 2009 | - | $403.90 K(-67.5%) |
| Dec 2008 | $1.24 M(-53.0%) | $1.24 M(-69.3%) |
| Sep 2008 | - | $4.04 M(+15.8%) |
| Jun 2008 | - | $3.49 M(-44.8%) |
| Mar 2008 | - | $6.33 M(+139.1%) |
| Dec 2007 | $2.65 M(-78.0%) | $2.65 M(-54.7%) |
| Sep 2007 | - | $5.84 M(-34.5%) |
| Jun 2007 | - | $8.92 M(-26.1%) |
| Mar 2007 | - | $12.06 M(+0.3%) |
| Dec 2006 | $12.02 M(+369.4%) | $12.02 M(-30.6%) |
| Sep 2006 | - | $17.33 M(-13.1%) |
| Jun 2006 | - | $19.93 M(+1780.5%) |
| Mar 2006 | - | $1.06 M(-58.6%) |
| Dec 2005 | $2.56 M(+200.6%) | $2.56 M(-41.2%) |
| Sep 2005 | - | $4.35 M(-15.0%) |
| Jun 2005 | - | $5.12 M(+199.2%) |
| Mar 2005 | - | $1.71 M(+100.8%) |
| Dec 2004 | $852.00 K(>+9900.0%) | $852.00 K(-18.0%) |
| Sep 2004 | - | $1.04 M(>+9900.0%) |
| Jun 2004 | - | $6200.00(+1966.7%) |
| Mar 2004 | - | $300.00(0.0%) |
| Dec 2003 | - | $300.00(-75.0%) |
| Sep 2003 | $1200.00(+1100.0%) | $1200.00(+500.0%) |
| Jun 2003 | - | $200.00(-50.0%) |
| Dec 2002 | - | $400.00(+300.0%) |
| Jun 2002 | - | $100.00(-97.0%) |
| Mar 2002 | - | $3300.00(+3200.0%) |
| Sep 2001 | $100.00(-99.3%) | $100.00(0.0%) |
| Jun 2001 | - | $100.00(-97.8%) |
| Mar 2001 | - | $4600.00(-57.8%) |
| Dec 2000 | - | $10.90 K(-26.8%) |
| Sep 2000 | $14.90 K(-19.5%) | $14.90 K(+67.4%) |
| Jun 2000 | - | $8900.00(-69.5%) |
| Mar 2000 | - | $29.20 K(+349.2%) |
| Dec 1999 | - | $6500.00(-64.9%) |
| Sep 1999 | $18.50 K | $18.50 K |
FAQ
- What is Acer Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Acer Therapeutics?
- What is Acer Therapeutics annual cash & cash equivalents year-on-year change?
- What is Acer Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Acer Therapeutics?
- What is Acer Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Acer Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of ACER is $2.33 M
What is the all time high annual cash & cash equivalents for Acer Therapeutics?
Acer Therapeutics all-time high annual cash & cash equivalents is $41.67 M
What is Acer Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, ACER annual cash & cash equivalents has changed by -$10.38 M (-81.68%)
What is Acer Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ACER is $1.55 M
What is the all time high quarterly cash and cash equivalents for Acer Therapeutics?
Acer Therapeutics all-time high quarterly cash and cash equivalents is $46.19 M
What is Acer Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, ACER quarterly cash and cash equivalents has changed by -$12.92 M (-89.26%)